Free tool
Drug Trial Radar: Dermatology
Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
2
Active, not recruiting, industry sponsors, Dermatology, Phase 1
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed141
2 trials
Showing 1 to 2, recently updated first.
- A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725Active, not recruiting
BioCryst PharmaceuticalsIndustry
NCT06539507 · 76 participants · Start Sep 26, 2024 · Primary completion Dec 2026
Drug: BCX17725; Placebo · For: Netherton Syndrome
Sites: Palo Alto, California; San Diego, California; New Haven, Connecticut · 12 sites in all
- Evaluate RLS-1496 Topical Cream for Actinic KeratosisActive, not recruiting
Rubedo Life Sciences, Inc.Industry
NCT07340697 · 24 participants (planned) · Start Feb 3, 2026 · Primary completion May 27, 2026
Drug: RLS-1496 1.0% cream · For: Actinic Keratosis (AK)
Sites: Hot Springs, Arkansas; New Brighton, Minnesota; Omaha, Nebraska · 4 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.